TRTürkçe
ENEnglish
AZAzərbaycanca
UZO‘zbekcha
ARالعربية
FRFrançais
DEDeutsch
RUРусский
GDP for Medicines: Inspection Preparation and Operational Evidence
A GDP preparation audit reviews evidence and operational gaps; it does not replace a competent authority’s inspection or authorisation decision. Define the country, medicine category, site and activities before setting the review scope. The human-medicine EU guideline is not an automatic checklist for every other product or jurisdiction.
A GDP preparation audit reviews evidence and operational gaps; it does not replace a competent authority’s inspection or authorisation decision. Define the country, medicine category, site and activities before setting…
Clarify whether the visit is an official inspection or preparation audit
A GDP preparation audit reviews evidence and operational gaps; it does not replace a competent authority’s inspection or authorisation decision. Define the country, medicine category, site and activities before setting the review scope. The human-medicine EU guideline is not an automatic checklist for every other product or jurisdiction.
Prepare responsibilities, current procedures, supplier and recipient checks, storage and transport evidence, deviations and recall records. Arrange access to the actual operations and responsible personnel. Checking a document index alone cannot demonstrate that the warehouse follows its own procedures.
Test whether storage evidence represents the current facility
The human-medicine GDP guideline calls for initial temperature mapping under representative conditions and repetition based on risk assessment or significant facility or temperature-control modifications. Monitoring positions should reflect the mapping results. Calibration arrangements should be justified for the equipment; no universal temperature or fixed interval is supplied here.
Hypothetically, a warehouse extends its storage room and changes the cooling outlets but presents only the old mapping study. The preparation review should compare old and current layouts, document the modification and identify the applicable new study and monitoring needs. A sensor’s calibration certificate alone does not represent the temperature distribution of the changed room.
Close findings through real work and accountable review
Record each gap, its responsible owner, necessary action and evidence of completion. Keep the basis for any qualification or risk decision and check whether staff can carry out the revised procedure. Explain missing evidence instead of recreating records retrospectively for the visit.
Kayra can coordinate an agreed preparation review and evidence organisation. The medicine business remains responsible for implementation; the authority makes the regulatory decision. An internal or private audit report is not an official GDP certificate, and this preparation example does not authorise use or release of any medicine batch.
Official sources
Official inspection and authorisation remain with the competent authority. The agreed preparation audit identifies operational evidence gaps; Kayra does not grant official conformity or make medicine-release decisions.
Does a preparation audit replace the authority inspection?
No. Its agreed purpose is gap review and preparation, separate from official inspection and authorisation.
Is the old temperature map enough after a major cooling change?
The applicable guideline requires repetition after significant modifications or according to risk assessment; assess the actual changed facility.
Does calibration alone prove the new room is mapped?
No. Calibration and representative temperature distribution evidence address different questions.
Tell us what you need and our specialists will contact you.
The exact records for GDP for Medicines: Inspection Preparation and Operational Evidence depend on the confirmed scope. Current, consistent and traceable information reduces avoidable revisions.